Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

About 69,000 new cases and nearly 14,000 deaths are expected this year, according to the American Cancer Society.

Joe Gebbia, a confidant of the technology billionaire and a Tesla director, is also a leader of the federal cost-cutting team ...

Two growth stocks in the healthcare industry stand out in particular. Here is what you need to know about each one and why ...

CVS says the decision to cover Wegovy and exclude Zepbound is "forcing the drug manufacturers to compete with one another" and will encourage both Eli Lilly and Novo Nordisk to lower prices for their ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

In the same way weight varies from person to person, so do the best weight loss strategies. While some people succeed with ...

A higher proportion of sleep medicine providers vs. patients reported CPAP over tirzepatide as their preferred treatment option for comorbid obesity and obstructive sleep apnea, according to data ...

From cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...

Eli Lilly and Company, Thermo Fisher Scientific, and Pfizer are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are equity shares ...

Some less expensive versions of popular weight loss drugs are no longer available to patients, after the Food & Drug ...

A Houston neurologist had his medical license suspended following his arrest on charges that accuse him of soliciting a minor ...